Analystreport

Ascendis Pharma A/S (NASDAQ: ASND) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Ascendis Pharma A/S - Ordinary Share  (ASND) 
Last ascendis pharma a/s - ordinary share earnings: 11/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ascendispharma.com